Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707187 · ClinicalTrials.gov registry record · Phase 2
Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
A Phase 2 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT00707187 is a Phase 2 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 120 participants.
The verdict
NCT00707187, a Phase 2 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud phenomenon as well as the vaginal dryness and discomfort associated with scleroderma
Interventions
- DRUG Cialis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2001-07 |
| Est. Completion | 2002-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00707187
The ClinicalTrials.gov registry entry for NCT00707187 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cialis is the first listed.
NCT00707187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00707187 about?
NCT00707187 is a clinical study titled "Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction". Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud phenomenon as well as the vag...
What is the current status of trial NCT00707187?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2001-07. Estimated completion is 2002-07.
What interventions are being tested in trial NCT00707187?
The interventions under investigation include: Cialis (DRUG).
Who is sponsoring clinical trial NCT00707187?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.